Austria Pharmaceutical and Medical Goods Expenditure Share (2024)
Austria's Pharmaceutical and Medical Goods Expenditure Share: 15.2 % of current health expenditure in 2024, -0.4pp YoY.
Austria (2024)
15.2
% of current health expenditure
-0.4pp YoY
YoY Change
-0.4pp
percentage points
Trend
down
Series length
9
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 15.2 | -0.4pp |
| 2023 | 15.6 | -0.1pp |
| 2022 | 15.7 | +0.2pp |
| 2021 | 15.5 | -0.9pp |
| 2020 | 16.4 | -0.2pp |
| 2019 | 16.6 | -0.2pp |
| 2018 | 16.8 | -0.1pp |
| 2017 | 16.9 | +0.1pp |
| 2016 | 16.8 | n/a |
About this Dataset
Austria recorded 15.2 % of current health expenditure in 2024. The latest change was -0.4pp. Across 2016–2024 the series ranges from 15.2 % of current health expenditure in 2024 to 16.9 % of current health expenditure in 2017.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Austria.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Austria. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2024 (9 observations).
The series is at its lowest recorded level, 15.2 % of current health expenditure in 2024, down from a peak of 16.9 % of current health expenditure in 2017. The latest change was -0.4pp.